CA
CELL

Clearstead Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Clearstead Advisors’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-80
Closed -$40 – 1579
2023
Q2 		$40 Hold
80
– – ﹤0.01% 1363
2023
Q1 		$93 Hold
80
– – ﹤0.01% 1352
2022
Q4 		$214 Hold
80
– – ﹤0.01% 1273
2022
Q3 		$0 Hold
80
– – ﹤0.01% 1391
2022
Q2 		$0 Hold
80
– – ﹤0.01% 1484
2022
Q1 		$1K Hold
80
– – ﹤0.01% 1347
2021
Q4 		$1K Hold
80
– – ﹤0.01% 1239
2021
Q3 		$2K Hold
80
– – ﹤0.01% 1166
2021
Q2 		$4K Hold
80
– – ﹤0.01% 942
2021
Q1 		$4K Buy
+80
New +$5.45K ﹤0.01% 902

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Clearstead Advisors's CELL Position: Q3 2023 in Review

Clearstead Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 80 shares — an estimated $40 sold.

Clearstead Advisors first reported a position in CELL in Q1 2021 and held it in 10 quarters. The position peaked at $4K in Q2 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Clearstead Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Clearstead Advisors sold 80 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $40.
  • Clearstead Advisors first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Clearstead Advisors's PhenomeX Inc. Common Stock position peaked at $4K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Clearstead Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.